NTLA 8-K 2026-09-04

Intellia Therapeutics, Inc. (NTLA) 8-K dated 2026-09-04 — accession 0001193125-26-383645. This URL is the filing, not the NTLA hub.

Intellia Therapeutics, Inc. (NTLA) is a biotechnology company listed on US.

Intellia Therapeutics, Inc. filed a 8-K on 2026-09-04. Accession 0001193125-26-383645.

Cached items: 1.01, 2.03, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.

Not investment advice. The NTLA SEC hub lists recent forms. The stock page is the research view.